Putting Nicotinic Compounds to Good Use along Tobacco Road

R.J. Reynolds’ spinoff Targacept is the leader in using nicotinic compounds for therapeutic benefit. Bill Caldwell, VP of drug discovery and development, tells why and shares tech transfer secrets in this exclusive audio interview.

By Paul Thomas, Managing Editor

1 vote
Text size: - +
Click the Download Now button to access this 2,173 KB mp3 audio file.

1 vote

Read more about

PharmaManufacturing.com is the site for knowledge, news and analysis for manufacturing and other professionals working in the pharmaceutical, biopharmaceutical and biotech industries.